The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-class monoclonal antibody (mAb) PBP1510 targeting pancreatic adenocarcinoma upregulated factor (PAUF) for pancreatic cancer (PC) treatment: Preclinical perspectives.
 
Kedar Diwakar Mandakhalikar
Employment - Prestige BioPharma
 
Sang Seok Koh
Employment - Prestige BioPharma
Research Funding - Prestige BioPharma
Patents, Royalties, Other Intellectual Property - Prestige BioPharma
 
Seong-Yun Jeong
No Relationships to Disclose
 
Deborah Moshinsky
Employment - Prestige BioPharma
Leadership - Prestige BioPharma
Consulting or Advisory Role - Prestige BioPharma
 
Peggy Feyaerts
No Relationships to Disclose
 
Ratna Karuna
Employment - Prestige BioPharma
 
Jamie Kim
Employment - Prestige BioPharma
 
Litha Jaison
Employment - Prestige BioPharma
 
Sumita Pradhan
Employment - Prestige BioPharma
 
Yeon Jeong Kim
Employment - Prestige BioPharma
Stock and Other Ownership Interests - Prestige BioPharma
Consulting or Advisory Role - Prestige BioPharma
Research Funding - Prestige BioPharma
 
Jin Park
No Relationships to Disclose